These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 21915059

  • 1. Placebo responses and placebo effects in functional bowel disorders.
    Enck P, Horing B, Weimer K, Klosterhalfen S.
    Eur J Gastroenterol Hepatol; 2012 Jan; 24(1):1-8. PubMed ID: 21915059
    [Abstract] [Full Text] [Related]

  • 2. The placebo response in functional bowel disorders: perspectives and putative mechanisms.
    Enck P, Klosterhalfen S.
    Neurogastroenterol Motil; 2005 Jun; 17(3):325-31. PubMed ID: 15916619
    [Abstract] [Full Text] [Related]

  • 3. Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5.
    Rösch W, Liebregts T, Gundermann KJ, Vinson B, Holtmann G.
    Phytomedicine; 2006 Jun; 13 Suppl 5():114-21. PubMed ID: 16978851
    [Abstract] [Full Text] [Related]

  • 4. The power of placebo in pediatric functional gastrointestinal disease.
    Benninga MA, Mayer EA.
    Gastroenterology; 2009 Oct; 137(4):1207-10. PubMed ID: 19717127
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [A depressive disorder in patients with irritable bowel syndrome and non-ulcer dyspepsia].
    Mine K, Kanazawa F, Matsumoto K, Tsuchida O, Hosoi M, Kubo C.
    Nihon Rinsho; 1994 May; 52(5):1329-33. PubMed ID: 8007409
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R, Nikfar S, Abdollahi M.
    Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
    [Abstract] [Full Text] [Related]

  • 9. Placebo responses in patients with gastrointestinal disorders.
    Musial F, Klosterhalfen S, Enck P.
    World J Gastroenterol; 2007 Jul 07; 13(25):3425-9. PubMed ID: 17659688
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. How effective are antidepressant medications in the treatment of irritable bowel syndrome and nonulcer dyspepsia?
    Pearson RL.
    J Fam Pract; 2000 May 07; 49(5):396. PubMed ID: 10836766
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
    Prescrire Int; 2009 Apr 07; 18(100):75-9. PubMed ID: 19585728
    [Abstract] [Full Text] [Related]

  • 15. Effect of asimadoline, a kappa opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome.
    Delvaux M, Beck A, Jacob J, Bouzamondo H, Weber FT, Frexinos J.
    Aliment Pharmacol Ther; 2004 Jul 15; 20(2):237-46. PubMed ID: 15233705
    [Abstract] [Full Text] [Related]

  • 16. Irritable bowel syndrome: a management strategy.
    Thompson WG.
    Baillieres Best Pract Res Clin Gastroenterol; 1999 Oct 15; 13(3):453-60. PubMed ID: 10580921
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hypnotherapy for functional gastrointestinal disorders.
    Drug Ther Bull; 2005 Jun 15; 43(6):45-8. PubMed ID: 15966557
    [Abstract] [Full Text] [Related]

  • 19. Clinical trial outcome in neuropathic pain: relationship to study characteristics.
    Katz J, Finnerup NB, Dworkin RH.
    Neurology; 2008 Jan 22; 70(4):263-72. PubMed ID: 17914067
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.